Assessment of salivary gland function after 177Lu-PSMA radioligand therapy: Current concepts in imaging and management

Prostate specific membrane antigen (PSMA) is a transmembrane protein that is highly expressed on prostate epithelial cells and is strongly upregulated in prostate cancer. Radioligand therapy using beta-emitting Lutetium-177 (177Lu)-labeled-PSMA-617, a radiolabeled small molecule, has gained attentio...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Sonia Mahajan, Ravinder K. Grewal, Kent P. Friedman, Heiko Schöder, Neeta Pandit-Taskar
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2022-07-01
Serija:	Translational Oncology
Teme:	177Lu-PSMA-617 Radioligand therapy Salivary gland dysfunction Xerostomia
Online dostop:	http://www.sciencedirect.com/science/article/pii/S1936523322001048
Oznake:	Označite Brez oznak, prvi označite!